Unethical informed consent caused by overlooking poorly measured nocebo effects

Journal of Medical Ethics 16:00-03 (2020)
Download Edit this record How to cite View on PhilPapers
Abstract
Unlike its friendly cousin the placebo effect, the nocebo effect (the effect of expecting a negative outcome) has been almost ignored. Epistemic and ethical confusions related to its existence have gone all but unnoticed. Contrary to what is often asserted, adverse events following from taking placebo interventions are not necessarily nocebo effects; they could have arisen due to natural history. Meanwhile, ethical informed consent (in clinical trials and clinical practice) has centred almost exclusively on the need to inform patients about intervention risks with patients to preserve their autonomy. Researchers have failed to consider the harm caused by the way in which the information is conveyed. In this paper, I argue that the magnitude of nocebo effects must be measured using control groups consisting of untreated patients. And, because the nocebo effect can produce harm, the principle of non-maleficence must be taken into account alongside autonomy when obtaining (ethical) informed consent and communicating intervention risks with patients.
Categories
(categorize this paper)
PhilPapers/Archive ID
HOWUIC-4
Upload history
First archival date: 2020-02-17
Latest version: 2 (2020-02-17)
View other versions
Added to PP index
2020-02-17

Total views
252 ( #18,879 of 53,009 )

Recent downloads (6 months)
94 ( #5,407 of 53,009 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.